Thrombolytic treatments: Indications;Indications des thrombolytiques

Reanimation Urgences

Volumn 10, Issue 5, 2001, Pages 484-486

  Charbonnier, B ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

ARTICLE; DIAGNOSTIC PROCEDURE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; FIBRINOLYTIC THERAPY; HUMAN; INTENSIVE CARE; LUNG EMBOLISM; PRACTICE GUIDELINE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0034900532     PISSN: 11646756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Guidelines on diagnosis and management of acute pulmonary embolism
2. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism
3. Proximal pulmonary emboli modify right ventricular ejection pattern
4. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism
5. Noninvasive diagnosis of suspected severe pulmonary embolism: Transesophageal echocardiography vs spiral CT
6. Diagnosis and treatment of shock due to massive pulmonary embolism: Approach with transesophageal echocardiography and intrapulmonary thrombolysis
7. Diagnostic accuracy of transesophageal echocardiography during cardiopulmonary resuscitation
8. Diagnosis of central pulmonary embolism with helical CT: Role of two-dimensional multiplanar reformations
9. Value of the ventilation perfusion lung scan in acute pulmonary embolism
10. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2
11. Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion
12. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial
13. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry
14. Hemodynamic effects of bolus versus two hour infusion of alteplase in acute massive pulmonary embolism. A randomised controlled multicenter trial
15. Reduced dose bolus alteplase versus conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomised trial
16. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: Immediate clinical and hemodynamic outcome and one year folow-up
17. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry
18. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors